McKesson Corporation
MCK
NYSE·Healthcare·Medical - Distribution·Mkt cap $106.3B
$907.99
▼ -1.45%
P/E
24.28
Mkt Cap
$106.3B
52-Wk Range
$683.38–$999.00
52-Week Range
$683.38 - $999.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 30.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Extensive nationwide distribution network
- Comprehensive healthcare technology platforms
- Strong relationships with pharmaceutical manufacturers
- Diversified revenue streams across healthcare segments
Bear Case
1 risk
- Low volatility (beta 0.3).
Growth
Stable outlook
Healthcare digitalization
Value
Fairly valued vs Healthcare Distribution peers
Momentum
Strong
+18.4% over 3m
Quality
Thin
Excellent business quality
Dividend
Token
0.37% yield
Smart-money signal
Who's buying MCK right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 5, 2026
Reported EPS of $9.93 vs $9.56 consensus (+3.9% surprise). Revenue of $105.4B vs $103.9B expected (+1.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+3.9%
Revenue trend · last 8Q
—
+18%
+19%
+23%
+10%
+11%
+6%
+8%
Q2 24
Q3 24
Q4 25
Q1 25
Q2 25
Q3 25
Q4 26
Q1 27
$93.7B
$95.3B
$90.8B
$97.8B
$103.2B
$106.2B
$96.3B
$105.4B
Margins · last 8Q
Gross
3.5%
Operating
1.3%
Profit
0.6%
Wall Street consensus
8 analysts · 88% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
88%
Hold
13%
Sell
0%
Median Price Target
—
Latest: Morgan Stanley · Aug 7, 2026
vs Industry
How MCK stacks vs Medical - Distribution
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related